WHO IS A GOOD CANDIDATE FOR SEMAGLUTIDE?
Semaglutide “Wegovy” is a medication used to treat type 2 diabetes and obesity. A good candidate for semaglutide typically includes individuals who meet specific criteria related to their health condition and treatment goals. Here are characteristics of individuals who may be considered good candidates for semaglutide:
- Type 2 Diabetes Diagnosis:
- Semaglutide is primarily indicated for individuals with type 2 diabetes. Good candidates are those with this specific diagnosis seeking additional medication to manage blood sugar levels.
- Inadequate Glycemic Control:
- Individuals with inadequate glycemic control on current diabetes medications may be suitable candidates for semaglutide. It is often considered when other treatments have not provided sufficient blood sugar management.
- Body Mass Index (BMI) Consideration:
- Semaglutide is also approved for the treatment of obesity. Good candidates may have a BMI indicating overweight or obesity, especially those who struggle with weight management as part of their diabetes management plan.
- Cardiovascular Considerations:
- Semaglutide has demonstrated cardiovascular benefits. Individuals with type 2 diabetes who have a history of cardiovascular disease or those at high risk for cardiovascular events may be good candidates for semaglutide.
- Commitment to Lifestyle Changes:
- Candidates for semaglutide are often individuals committed to making positive lifestyle changes, including adopting a healthy diet and engaging in regular physical activity.
- Preference for Once-Weekly Dosing:
- Semaglutide is administered once a week. Good candidates may prefer the convenience of a once-weekly dosing schedule compared to more frequent injections.
- Absence of Contraindications:
- Individuals without contraindications or specific health conditions that may pose risks with semaglutide use are considered good candidates. A thorough medical evaluation is essential.
- Patient Preferences:
- Patient preferences and willingness to adhere to the treatment plan are crucial. Good candidates are those who are motivated and willing to follow the prescribed regimen.
SEMAGLUTIDE PEPTIDE FAQ
Semaglutide is a powerful active ingredient that’s used in three distinct treatments depending on the condition. Wegovy (semaglutide) assists with weight management, while Ozempic and Rybelsus are intended for those managing Type 2 diabetes. The applications of semaglutide vary – it can be injected weekly under the skin via Wegovy or as a lower dose through Ozempic, or taken orally every day with Rybelsus tablets.
After 12 months, individuals taking Wegovy (semaglutide) supplemented with physical activity and a balanced diet achieved on average an impressive 10-16% reduction in body weight. Even more noteworthy was the 16% drop off reported in BMI among children following this same regimen – highlighting its potential efficacy for helping youngsters reach healthier states. [source GoodRX.com]
Administering Wegovy (semaglutide) is an important step in your healthcare routine. Be sure to review the instructions carefully before beginning, as proper injection protocol should be followed for best results. Begin by washing your hands and preparing a clean surface on which to inject – using either soap and water or an alcohol swab will suffice. Then firmly press the pen straight into skin until two clicks can heard – indicating that both injecting has begun, then paused once all medication has been administered properly.. To ensure you receive a complete dose of this vital medication, hold the pen against skin until its yellow bar stops moving through the window viewport!
If you have forgotten a dose of Wegovy (semaglutide), take it as soon as possible if more than 2 days have passed. Otherwise, wait until your next scheduled day to take the medication. However, should two weeks pass without taking any doses, contact your healthcare provider right away for further guidance.
Wegovy / Ozempic (semaglutide) should always be stored in the refrigerator to maintain its quality – but if you forget, it’s okay to use for up to 28 days at room temperature as long as it hasn’t been opened and exposed. If either of those conditions occur, don’t risk administering Wegovy from this pen – throw it away immediately in a sharps disposal container!
Wegovy (semaglutide) is not a safe option for pregnant individuals, as it can cause harm to the unborn baby. There have been cases of birth defects and miscarriages in animals given semaglutide during experiments, prompting cautiousness about its use among humans expecting. To avoid any risks associated with Wegovy (semaglutide), one should stop taking the medication at least two months before getting pregnant and contact Novo Nordisk’s 1-800 number if they’ve already taken/are currently using semagluitde while carrying an infant – their optional pregnancy exposure registry will track health outcomes of both mother and child.
Semaglutide management and side effects
To achieve the best outcomes, Wegovy / Ozempic (semaglutide) should be taken together with a balanced low-calorie diet and regular exercise. Dr. Carlos Sanchez will raise your dose incrementally as needed every 4 weeks to maintain effectiveness of the semaglutide. We also monitor side effects at all times. Most common side effects are stomach or GI related such as nausea, constipation and in rare cases significant abdominal pain due to gallstones or pancreatitis. We may choose to reduce your dosage or even stop medication until it’s safe for you again. We encourage patients to let us know immediately if you are having any of theses side effects especially abdominal pain.
- Monday9:00 - 5:00
- Tuesday9:00 - 5:00
- Wednesday9:00 - 5:00
- Thursday9:00 - 5:00
- Friday9:00 - 5:00
- SaturdayBY APPT ONLY
- SundayClosed
